About
Origami Therapeutics develops next-generation protein degradation and correction therapies specifically targeting neurodegenerative diseases such as Huntington’s Disease, Alzheimer’s, and Parkinson’s.
Explore Origami Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.